Suppr超能文献

高迁移率族蛋白 B1 及其在肿瘤中双向调控的机制。

The mechanism of high mobility group box-1 protein and its bidirectional regulation in tumors.

机构信息

The Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, China.

Oral Disease Research Key Laboratory of Guizhou Tertiary Institution, School of Stomatology, Zunyi Medical University, Zunyi, China.

出版信息

Biomol Biomed. 2024 May 2;24(3):477-485. doi: 10.17305/bb.2023.9760.

Abstract

High-mobility group box-1 protein (HMGB1) is a nonhistone chromatin-related protein widely found in eukaryotic cells. It is involved in the transcription, replication, and repair of DNA to maintain nuclear homeostasis. It participates in cell growth, differentiation, and signal transduction. Recent studies showed that HMGB1 has a bidirectional regulatory effect on tumors by regulating TLR4/MYD88/NF-κB and RAGE/AMPK/mTOR signaling pathways. On the one hand, it is highly expressed in a variety of tumors, promoting tumor proliferation and invasion, while on the other hand, it induces autophagy and apoptosis of tumor cells and stimulates tumor-infiltrating lymphocytes to produce an anti-tumor immune response. At present, HMGB1 could be used as a target to regulate the drug resistance and prognostication in cancer. Clinical applications of HMGB1 in cancer need further in-depth studies.

摘要

高迁移率族蛋白 B1(HMGB1)是一种广泛存在于真核细胞中的非组蛋白染色质相关蛋白。它参与 DNA 的转录、复制和修复,以维持核内稳态。它参与细胞的生长、分化和信号转导。最近的研究表明,HMGB1 通过调节 TLR4/MYD88/NF-κB 和 RAGE/AMPK/mTOR 信号通路对肿瘤具有双向调节作用。一方面,它在多种肿瘤中高表达,促进肿瘤增殖和侵袭,另一方面,它诱导肿瘤细胞自噬和凋亡,并刺激肿瘤浸润淋巴细胞产生抗肿瘤免疫反应。目前,HMGB1 可以作为一个靶点来调节癌症的耐药性和预后。HMGB1 在癌症中的临床应用需要进一步深入研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a2a/11088895/312ce2f0d9a8/bb-2023-9760f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验